ArticleClinical pharmacology and therapeutics2026

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients.

Anita Iacono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.